Treatment options for nail psoriasis

References

• de Berker D. Diagnosis and management of nail psoriasis. Dermatol. Ther.15, 165–172 (2002).
   Google Scholar
• Gladman DD, Anhorn KA, Schachter RK, Mervart H. HLA antigens in psoriatic arthritis. J. Rheumatol.13, 586–592 (1986).
   PubMed Web of Science ®Google Scholar
• de Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology193, 300–303 (1996).
   PubMed Web of Science ®Google Scholar
• Gupta AK, Lynde CW, Jain HC et al. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study. Br. J. Dermatol.136, 786–789 (1997).
   PubMed Web of Science ®Google Scholar
• Szepietowski JC, Salomon J. Do fungi play a role in psoriatic nails? Mycoses50, 437–442 (2007).
   PubMed Web of Science ®Google Scholar
• Gianni C, Morelli V, Cerri A et al. Usefulness of histological examination for the diagnosis of onychomycosis. Dermatology202, 283–288 (2001).
   PubMed Web of Science ®Google Scholar
• Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J. Am. Acad. Dermatol.49, 206–212 (2003).
   PubMed Web of Science ®Google Scholar
• Cassell SE, Bieber JD, Rich P et al. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J. Rheumatol.34, 123–129 (2007).
   PubMed Web of Science ®Google Scholar
• Kaçar N, Ergin S, Erdoan BS. The comparison of Nail Psoriasis Severity Index with a less time-consuming qualitative system. J. Eur. Acad. Dermatol. Venereol.22, 219–222 (2008).
   PubMedGoogle Scholar
• Parrish CA, Sobera JO, Elewski BE. Modification of the Nail Psoriasis Severity Index. J. Am. Acad. Dermatol.53, 745–746 (2005).
   PubMed Web of Science ®Google Scholar
• Baran RL. A nail psoriasis severity index. Br. J. Dermatol.150, 568–569 (2004).
   PubMed Web of Science ®Google Scholar
• Piraccini BM, Tosti A, Iorizzo M, Misciali C. Pustular psoriasis of the nails: treatment and long-term follow-up of 46 patients. Br. J. Dermatol.144, 1000–1005 (2001).
   PubMed Web of Science ®Google Scholar
• Tosti A, Piraccini BM, Cameli N et al. Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid. Br. J. Dermatol.139, 655–659 (1998).
   PubMed Web of Science ®Google Scholar
• Rigopoulos D, Ioannides D, Prastitis N, Katsambas A. Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream. Acta Derm. Venereol.82, 140 (2002).
   PubMed Web of Science ®Google Scholar
• Rigopoulos D, Gregoriou S, Katsambas A. Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study. Acta Derm. Venereol.87, 167–168 (2007).
   PubMed Web of Science ®Google Scholar
• Sánchez Regaña M, Martín Ezquerra G, Umbert Millet P, Llambí Mateos F. Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients. J. Eur. Acad. Dermatol. Venereol.19, 573–577 (2005).
   PubMedGoogle Scholar
• Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J. Am. Acad. Dermatol.57, 1–27 (2007).
   PubMed Web of Science ®Google Scholar
• de Berker DA, Lawrence CM. A simplified protocol of steroid injection for psoriatic nail dystrophy. Br. J. Dermatol.138, 90–95 (1998).
   PubMed Web of Science ®Google Scholar
• Abell E. Treatment of psoriatic nail dystrophy. Br. J. Dermatol.86, 79–82 (1972).
   PubMedGoogle Scholar
• Abell E, Samman PD. Intradermal triamcinolone treatment of nail dystrophies. Br. J. Dermatol.89, 191–197 (1973).
   PubMed Web of Science ®Google Scholar
• Peachey RD, Pye RJ, Harman RR. The treatment of psoriatic nail dystrophy with intradermal steroid injections. Br. J. Dermatol.95, 75–78 (1976).
   PubMed Web of Science ®Google Scholar
• Bleeker JJ. Letter: intradermal triamcinolone acetonide treatment of psoriatic nail dystrophy with Port-o-Jet. Br. J. Dermatol.92, 479 (1975).
   PubMedGoogle Scholar
• Bleeker JJ. Intralesional triamcinolone acetonide using the Port-O-Jet and needle injections in localized dermatoses. Br. J. Dermatol.91, 97–101 (1974).
   PubMedGoogle Scholar
• Bedi TR. Intradermal triamcinolone treatment of psoriatic onychodystrophy. Dermatologica155, 24–27 (1977).
   PubMedGoogle Scholar
• Zakeri M, Valikhani M, Mortazavi H, Barzegari M. Topical calcipotriol therapy in nail psoriasis: a study of 24 cases. Dermatol. Online J.11, 5 (2005).
   PubMedGoogle Scholar
• Feliciani C, Zampetti A, Forleo P et al. Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol. J. Cutan. Med. Surg.8, 122–125 (2004).
   PubMedGoogle Scholar
• Cannavò SP, Guarneri F, Vaccaro M, Borgia F, Guarneri B. Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study. Dermatology206, 153–156 (2003).
   PubMedGoogle Scholar
• Scher RK, Stiller M, Zhu YI. Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study. Cutis68, 355–358 (2001).
   PubMed Web of Science ®Google Scholar
• Bianchi L, Soda R, Diluvio L, Chimenti S. Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective study. Br. J. Dermatol.149, 207–209 (2003).
   PubMed Web of Science ®Google Scholar
• Fredriksson T. Topically applied fluorouracil in the treatment of psoriatic nails. Arch. Dermatol.110, 735–736 (1974).
   PubMedGoogle Scholar
• Fritz K. Successful local treatment of nail psoriasis with 5-fluorouracil. Z. Hautkr.15(64), 1083–1088 (1989).
   Google Scholar
• de Jong EM, Menke HE, van Praag MC, van De Kerkhof PC. Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study. Dermatology199, 313–318 (1999).
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Katayama I, Nishioka K. Topical anthralin therapy for refractory nail psoriasis. J. Dermatol.25(4), 231–233 (1998).
   PubMedGoogle Scholar
• Mahrle G, Schulze HJ, Färber L, Weidinger G, Steigleder GK. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. J. Am. Acad. Dermatol.32, 78–88 (1995).
   PubMed Web of Science ®Google Scholar
• Feliciani C, Zampetti A, Forleo P et al. Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol. J. Cutan. Med. Surg.8, 122–125 (2004).
   PubMedGoogle Scholar
• Marx JL, Scher RK. Response of psoriatic nails to oral photochemotherapy. Arch. Dermatol.116(9), 1023–1024 (1980).
   PubMedGoogle Scholar
• Yu RC, King CM. A double-blind study of superficial radiotherapy in psoriatic nail dystrophy. Acta Derm. Venereol.72, 134–136 (1992).
   PubMed Web of Science ®Google Scholar
• Cassell S, Kavanaugh AF. Therapies for psoriatic nail disease. A systematic review. J. Rheumatol.33, 1452–1456 (2006).
   PubMed Web of Science ®Google Scholar
• Cassetty CT, Alexis AF, Shupack JL, Strober BE. Alefacept in the treatment of psoriatic nail disease: a small case series. J. Am. Acad. Dermatol.52, 1101–1102 (2005).
   PubMed Web of Science ®Google Scholar
• Körver JE, Langewouters AM, Van De Kerkhof PC, Pasch MC. Therapeutic effects of a 12-week course of alefacept on nail psoriasis. J. Eur. Acad. Dermatol. Venereol.20, 1252–1255 (2006).
   PubMed Web of Science ®Google Scholar
• Reich K, Nestle FO, Papp K et al.; EXPRESS study investigators. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a Phase III, multicentre, double-blind trial. Lancet366, 1367–1374 (2005).
   PubMed Web of Science ®Google Scholar
• Bianchi L, Bergamin A, de Felice C, Capriotti E, Chimenti S. Remission and time of resolution of nail psoriasis during infliximab therapy. J. Am. Acad. Dermatol.52, 736–737 (2005).
   PubMed Web of Science ®Google Scholar
• Lawry M. Biological therapy and nail psoriasis. Dermatol. Ther.20, 60–67 (2007).
   PubMed Web of Science ®Google Scholar
• de Berker DA, Baran R, Dawber RP. The nail in dermatological diseases. In: Baran and Dawber’s Diseases of the Nails and Their Management (3rd Edition). Blackwell Sciences Ltd, Oxford, UK 172–222 (2001).
   Google Scholar